Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Graeme Wylie Centre for Integrated Health Care Research,
Wolfson Research Institute, University of Durham, Stockton-on-Tees TS17
6BH
Correspondence to: G Wylie
graeme.wylie{at}dur.ac.uk
Objective:
To investigate general practitioners'
knowledge of and attitudes to impaired glucose tolerance.
What is already known on this topic
Lifestyle intervention can significantly reduce the progression to
diabetes, although the evidence for reduction in cardiovascular disease
is less compelling What this study adds
General practitioners are uncertain how best to manage and follow up
patients with established impaired glucose tolerance General practitioners are reluctant to screen patients for impaired
glucose tolerance for a variety of reasons
Design:
Mixed methodology qualitative and
quantitative study with semistructured interviews, focus groups, and questionnaires.
Setting:
34 general practitioners in five primary
care groups in the north east of England.
Results:
All the general practitioners had knowledge of impaired glucose tolerance as a clinical entity, but they had little
awareness of the clinical significance of impaired glucose tolerance
and were uncertain about managing and following up these patients.
Attitudes to screening were mixed and were associated with reservations
about increased workload, concern about lack of resources, and
pessimism about the effectiveness of lifestyle interventions. Some
general practitioners felt strongly that screening patients for
impaired glucose tolerance and subsequent lifestyle intervention
medicalised an essentially social problem and that a health educational
approach, involving schools and the media, should be adopted instead.
A minority expressed a positive attitude towards a pharmacological approach.
Conclusion:
Awareness of impaired glucose tolerance
needs to be raised, and guidelines for management are needed. General practitioners remain to be convinced that they have a role in attempting to reduce the incidence of type 2 diabetes by targeting interventions at patients with impaired glucose tolerance.
Impaired glucose tolerance is common and carries a 50% risk of
progression to type 2 diabetes within 10 years of diagnosis and a
doubling of the risk of developing cardiovascular disease
Awareness of the clinical significance of impaired glucose tolerance
among general practitioners is low
© BMJ 2002
Read all Rapid Responses